Herbert Chiou
University of Sydney
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Herbert Chiou.
Pharmaceutical Research | 2007
Matthew S. Coates; Hak-Kim Chan; David F. Fletcher; Herbert Chiou
PurposeTo investigate the influence of mouthpiece geometry on the amount of throat deposition and device retention produced using a dry powder inhaler (Aerolizer®), along with the subsequent effect on the overall inhaler performance.Materials and MethodsComputational Fluid Dynamics analysis of the flowfield generated in the Aerolizer® with various modified mouthpiece geometries (including cylindrical, conical and oval designs) was used in conjunction with experimental dispersions of mannitol powder using a multi-stage liquid impinger to determine how the overall inhaler performance varied as the mouthpiece geometry was modified.ResultsGeometry of the inhaler mouthpiece had no effect on device retention or the inhaler dispersion performance. In contrast, the mouthpiece geometry strongly affected the amount of throat deposition by controlling the axial component of the exit air flow velocity. The radial motion of the emitted aerosol jet was found to have little effect on throat deposition in representative mouth–throat models. Despite the reduced throat deposition, there was no difference in the overall inhaler performance.ConclusionsFor cases where low throat deposition is a key design parameter, this study demonstrates that the amount of throat deposition can be reduced by making minor modifications to the inhaler mouthpiece design.
Drug Development and Industrial Pharmacy | 2007
Paul M. Young; Herbert Chiou; Terrance Tee; Daniela Traini; Hak-Kim Chan; Frank Thielmann; Daniel J. Burnett
ABSTRACT Organic dynamic vapor sorption (organic-DVS) was used to characterize amorphous content in known amorphous-crystalline mixtures of lactose and salbutamol sulfate. N-octane was chosen as an apolar probe and measurements were carried out by exposing mixtures of each sample to partial pressures 0–90% p/p0. A linear relationship between amorphous content and n-octane partial pressure was observed for both lactose and salbutamol sulfate with R2 values of 0.992 and 0.999, respectively. In addition, the influence of sequential mechanical processing in a ball mill on the amorphous content in crystalline lactose was investigated. Cumulative milling times resulted in an exponential increase in amorphous content (using the linear relationship obtained for lactose), with a maximum amorphous content of 14% being induced after 60 min milling. In comparison, analysis of the 60 min mill time samples after exposure to 85% relative humidity suggested 0.00% amorphous content.
International Journal of Pharmaceutics | 2009
Patricia Tang; Hak-Kim Chan; Herbert Chiou; Keiko Ogawa; Matthew Jones; Handoko Adi; Graham Buckton; R.k. Prud’homme; Judy A Raper
Mannitol particles, produced by spray drying (SD), have been used commercially (Aridol) in bronchial provocation test. In this study, we propose an alternative method to produce inhalable mannitol powders. The elongated mannitol particles (number median length 4.0microm, and axial ratio of 3.5) were prepared using a confined liquid impinging jets (CLIJs) followed by jet milling (JM). Spray dried and jet milled raw mannitol particles were compared in an attempt to assess the performance of the particles produced by the new method. Aerosol performance of the three different powders (CLIJ, SD, and JM) was relatively poor (fine particle fraction or FPF(loaded) below 15%) when dispersed by the Rotahaler. Dispersion through the Aeroliser led to better aerosol performance of the CLIJ mannitol (FPF(loaded) 20.3%), which is worse than the JM (FPF(loaded) 30.3%) and SD mannitol particles (FPF(loaded) 45.7%) at 60 L/min, but comparable (FPF(loaded) 40.0%) with those of the JM (FPF(loaded) 40.7%) and SD (FPF(loaded) 45.5%) powders at 100L/min. Hence, the optimum use of these elongated mannitol particles can be achieved at increased air flow with a more efficient inhaler. In addition to crystallinity, morphology, and particle size distribution, the surface energies of these powders were measured to explain the differences in aerosol performance. A major advantage of using the CLIJ method is that it can be scaled up with a good yield as the precipitate can be largely collected and recovered on a filter, compared with spray drying which has a low collection efficiency for fine particles below 2microm.
Drug Development and Industrial Pharmacy | 2008
Herbert Chiou; Hak-Kim Chan; Robert K. Prud'homme; Judy A Raper
Most pharmaceutical compounds can benefit from being produced with a small particle size to enhance processing or therapeutic performance. Confined liquid impinging jets (CLIJ) were employed in this study to evaluate the feasibility and limitations in the production of nanodrugs (i.e., particle size in the nanorange). Four drugs from different pharmaceutical classes and water solubilities—salbutamol sulfate, mannitol, ibuprofen, and cyclosporine—were examined. Particles of salbutamol sulfate and cyclosporine with diameters of approximately 300 nm were successfully achieved. The use of CLIJ thus shows potential in the production of nanopharmaceuticals for certain compounds.
Expert Opinion on Drug Delivery | 2006
Hak-Kim Chan; Herbert Chiou; Philip Chi Lip Kwok
This international meeting brought together ∼ 250 delegates from the pharmaceutical industry, academia, hospitals and government agencies, to discuss the latest research and development on areas related to inhalation aerosols. Fundamental science and applied research encompassing both the biological and physicochemical aspects were presented. There was a wide range of topics covered, from immune modulation to pharmaceutical regulatory issues, including aerosol clearance; industry innovations; aerosols and in utero effects; technical advances in imaging; inhalation catastrophes; as well as recent advances and future directions in aerosol delivery systems. This biennial congress has provided an excellent forum for stimulating fruitful discussion of aerosols in medicine.
Pharmaceutical Research | 2007
Paul M. Young; Adrian Sung; Daniela Traini; Philip Chi Lip Kwok; Herbert Chiou; Hak-Kim Chan
Pharmaceutical Research | 2006
Handoko Adi; Ian Larson; Herbert Chiou; Paul M. Young; Daniela Traini; Peter Stewart
International Journal of Pharmaceutics | 2007
Herbert Chiou; Liang Li; Tingting Hu; Hak-Kim Chan; Jian-Feng Chen; Jimmy Yun
Journal of Pharmaceutical Sciences | 2007
Paul M. Young; Hak-Kim Chan; Herbert Chiou; Stephen Edge; Terence H.S. Tee; Daniela Traini
Chemical Engineering Science | 2007
Ali Abbas; Mourtada Srour; Patricia Tang; Herbert Chiou; Hak-Kim Chan; Jose A. Romagnoli